abstract |
A composition including a CXCR4 antagonist and a CCR5 antagonist represented by formula I or II: or an acceptable salt, solvate or ester thereof. The GXCR4 antagonist includes at least one of AMD-070. CS-3955, KRH-1 120, KRH-2731, and KRH-1636. These compositions are used to manufacture medicaments for the treatment of HIV infections. |